NAMPT INHIBITION AND INCREASED NAD-BIOAVAILABILITY ATENUATE LIVER DAMAGE IN CCl4-INDUCED MICE CHRONIC LIVER DISEASE
J.A. Gutiérrez buendía1, R. Pérez Cabeza de Vaca3, G.A. Domínguez Pérez1, E. Vera Gomez1, A. Hernández Patricio1, K. Moreno Vega1, M. Salamanca García2, J.I. Bustamante Santillan3, P. Mondragón Terán3, R. Hernández Muñoz3, J.A. Suárez Cuenca1
1 Experimental Metabolism Laboratory. Biomedical Research Division. National Medical Center “20 de Noviembre” – ISSSTE. Anatomical Pathology Department NMC “20 de Noviembre” ISSSTE. México City, México
2 Biomedical Research Coordination NMC “20 de November” – ISSSTE. México City, México
3 Cellular Biology and Development Department – IFC – UNAM. México City, México
Read
755
Timeswas read the article
283
Total PDF
472
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 24 | 2 | 26 |
| 2025 11 | 79 | 25 | 104 |
| 2025 10 | 18 | 10 | 28 |
| 2025 9 | 35 | 12 | 47 |
| 2025 8 | 14 | 11 | 25 |
| 2025 7 | 30 | 7 | 37 |
| 2025 6 | 6 | 8 | 14 |
| 2025 5 | 15 | 1 | 16 |
| 2025 4 | 9 | 7 | 16 |
| 2025 3 | 13 | 5 | 18 |
| 2025 2 | 7 | 4 | 11 |
| 2025 1 | 10 | 1 | 11 |
| 2024 12 | 4 | 4 | 8 |
| 2024 11 | 21 | 5 | 26 |
| 2024 10 | 6 | 3 | 9 |
| 2024 9 | 5 | 3 | 8 |
| 2024 8 | 6 | 2 | 8 |
| 2024 7 | 10 | 5 | 15 |
| 2024 6 | 8 | 3 | 11 |
| 2024 5 | 8 | 3 | 11 |
| 2024 4 | 7 | 3 | 10 |
| 2024 3 | 5 | 2 | 7 |
| 2024 2 | 5 | 8 | 13 |
| 2024 1 | 8 | 7 | 15 |
| 2023 12 | 3 | 9 | 12 |
| 2023 11 | 7 | 13 | 20 |
| 2023 10 | 7 | 14 | 21 |
| 2023 9 | 14 | 7 | 21 |
| 2023 8 | 2 | 4 | 6 |
| 2023 7 | 3 | 4 | 7 |
| 2023 6 | 4 | 3 | 7 |
| 2023 5 | 4 | 4 | 8 |
| 2023 4 | 3 | 2 | 5 |
| 2023 3 | 2 | 1 | 3 |
| 2023 2 | 1 | 6 | 7 |
| 2023 1 | 4 | 8 | 12 |
| 2022 12 | 2 | 3 | 5 |
| 2022 11 | 5 | 4 | 9 |
| 2022 10 | 4 | 6 | 10 |
| 2022 9 | 6 | 7 | 13 |
| 2022 8 | 8 | 6 | 14 |
| 2022 7 | 6 | 7 | 13 |
| 2022 6 | 4 | 6 | 10 |
| 2022 5 | 8 | 10 | 18 |
| 2022 4 | 7 | 4 | 11 |
| 2022 3 | 10 | 7 | 17 |
| 2022 2 | 5 | 7 | 12 |
Show all
